When is Abnehmspritze Frauen actually useful?

Weight loss injections (GLP-1 agonists like semaglutide, liraglutide) are useful for women when prescribed according to approved indications: obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity (e.g., type 2 diabetes, hypertension). Large randomized controlled trials (STEP program) demonstrate 10–15% weight loss when combined with lifestyle modification. However, they are not a quick fix: sustained dietary changes and physical activity are essential to maintain results. Common side effects (nausea, vomiting, diarrhea) can limit tolerability. Long-term safety beyond 2–3 years is not fully established. These drugs are contraindicated during pregnancy or if planning pregnancy. Cost is often out-of-pocket. Social media hype exaggerates benefits and downplays risks. Medical supervision is mandatory. For women without medical necessity (e.g., mild overweight without comorbidities), the risk-benefit ratio is unfavorable. Evidence: human-strong (RCTs).